PREMIUM TIMES
The Nigerian government has approved a new malaria vaccine from Oxford University, becoming the second country after Ghana in the world to grant such approval.
The vaccine- R21/Matrix-M, is developed by the University of Oxford and manufactured by the Serum Institute of India.
The Director General of Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC), Mojisola Adeyeye, announced the development on Monday in Abuja.
Similar to Ghana, Mrs Adeyeye said the vaccine is indicated for the prevention of malaria in children from 5 months to 36 months of age.
She added that Nigeria expects to get at least 100,000 doses of the vaccine in donations soon before the market authorisation will start making other arrangements with the National Primary Health Care Development Agency…
